In the first half of 2023, the slowdown in terms of global life sciences M&A deal-making experienced in the second half of 2022 has continued to show its effects. Anticipated as a year of recovery, 2023 was expected to leverage M&A as a means to adapt to rapidly changing market conditions. However, while it remains … Continue reading Life Sciences M&A Report: Half-Year 2023
Introducing M&A deals to Biotechgate
Biotechgate is continuously working on enhancements and new tools to boost the experience for our users. Currently, Biotechgate is developing a new release, which is planned for early 2024: Among the various new features that subscribers can look forward to, one in particular worth highlighting revolves around M&A deals and is unique on the market … Continue reading Introducing M&A deals to Biotechgate
Interoperability in Digital Health: Driving Innovation for Better Patient Care
Data interoperability in the digital health industry is more than just a buzzword: It stands for the potential to transform the way healthcare providers exchange electronic patient data. In this article, we will explore the importance of interoperability and the challenges it faces. Find out how to discover companies in Biotechgate that lead the development … Continue reading Interoperability in Digital Health: Driving Innovation for Better Patient Care
Financing in Digital Health: An Overview
Digital health is an industry in the life sciences experiencing constant innovation as well as attention from both investors and fellow companies. The Biotechgate Business Development Database contains an array of up-to-date information on digital health. In this article, you’ll find an overview of how funding in the industry has developed and further analysis of … Continue reading Financing in Digital Health: An Overview
Digital Health Categorization in Biotechgate Explained
Previously referred to as HealthTech, the digital health category is one of the six core company sectors in the Biotechgate database. Read our brief overview on what exactly this area consists of and how we define companies that fall under the digital health umbrella. The digital health sector does not always fit into the common … Continue reading Digital Health Categorization in Biotechgate Explained
Venture Valuation/Biotechgate and One Nucleus Partner to Boost Life Sciences Connectivity and Innovation
Zurich, Switzerland and Cambridge, UK, September 2023 – Biotechgate, a leading global life sciences business development and licensing database and One Nucleus, a Cambridge, UK-based life sciences and healthcare membership organisation, are thrilled to announce a collaboration to boost life sciences connectivity and innovation. The purpose of this collaboration is to provide a reliable hub … Continue reading Venture Valuation/Biotechgate and One Nucleus Partner to Boost Life Sciences Connectivity and Innovation
Norway Life Science Trend Analysis 2023
The Norwegian life sciences industry performed well in 2022 compared to the years before 2021 (2018 – 2020), raising USD 38 million in private equity investments according to Biotechgate data. However, it could not compete with the record level of venture financing in 2021 (USD 65 million). Cytovation ASA secured the largest round in 2022. … Continue reading Norway Life Science Trend Analysis 2023
The Top 5 Biggest Licensing Deals of 2023 So Far
As biotechs face a challenging commercial environment with limited options for IPOs, interest in forging partnership agreements remains high. This article explores five top biotech and pharma licensing deals, ranked by the potential total deal value, that 2023 has brought to date. From advancing precision oncology to regenerative medicine, these partnerships underscore a commitment to … Continue reading The Top 5 Biggest Licensing Deals of 2023 So Far
Biotech Product Valuation: Setting a Price for Acquisitions
Navigating the complex landscape of biotech valuations is often more of an art than a science. This article shows the methodologies and considerations implemented when assessing biotech products in a field where industry meets commerce. Big acquisitions like the purchase earlier in 2023 by Merck of Prometheus Biosciences are very good examples of how valuation … Continue reading Biotech Product Valuation: Setting a Price for Acquisitions
Venture Valuation/Biotechgate and AdvaMed Form Strategic Partnership to Drive MedTech Industry Growth
Media Release Zurich, Switzerland and Washington, D.C., USA, August 2023 – Biotechgate, a global business development and licensing database for the life sciences industry, is proud to announce its strategic partnership with the Advanced Medical Technology Association (AdvaMed). This collaboration aims to strengthen the data integration in Biotechgate, while enhancing the visibility and insight into … Continue reading Venture Valuation/Biotechgate and AdvaMed Form Strategic Partnership to Drive MedTech Industry Growth